M. Scott Harris
2022
In 2022, M. Scott Harris earned a total compensation of $1.4M as Chief Medical Officer at PharmAthene, a 36% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $182,400 |
---|---|
Option Awards | $572,395 |
Salary | $456,000 |
Stock Awards | $234,183 |
Other | $4,640 |
Total | $1,449,618 |
Harris received $572.4K in option awards, accounting for 39% of the total pay in 2022.
Harris also received $182.4K in non-equity incentive plan, $456K in salary, $234.2K in stock awards and $4.6K in other compensation.
Rankings
In 2022, M. Scott Harris' compensation ranked 2,253rd out of 5,503 executives tracked by ExecPay. In other words, Harris earned more than 59.1% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 2,253 | 59th |
Manufacturing | 1,216 | 59th |
Chemicals And Allied Products | 538 | 60th |
Drugs | 493 | 60th |
Pharmaceutical Preparations | 357 | 60th |
Harris' colleagues
We found three more compensation records of executives who worked with M. Scott Harris at PharmAthene in 2022.